Humacyte (NASDAQ:HUMA) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen downgraded shares of Humacyte (NASDAQ:HUMA – Free Report) from a hold rating to a sell rating in a report issued on Saturday. Other research analysts have also recently issued research reports about the company. Benchmark reduced their price objective on Humacyte from $17.00 to $14.00 and set a “buy” rating on the […]
Wall Street Zen downgraded shares of Humacyte (NASDAQ:HUMA – Free Report) from a hold rating to a sell rating in a report issued on Saturday. Other research analysts have also recently issued research reports about the company. Benchmark reduced their price objective on Humacyte from $17.00 to $14.00 and set a “buy” rating on the […]
